The process begins when a hapten, a small molecule that becomes antigenic only when attached to a larger carrier, binds to cell membranes. The immune system then falsely identifies these cells as threats. Upon subsequent exposure, the immune system produces antibodies targeting these hapten-carrier complexes, leading to the activation of the complement cascade or antibody-dependent cell-mediated cytotoxicity (ADCC).
